Dasatinib Tablets 100 Mg – Generic Sprycel

Dasatinib Tablets 100 Mg – Generic Sprycel

Dasatinib Tablets 100 Mg – Generic Sprycel is a targeted anticancer medication used primarily in the treatment of certain types of leukemia, including chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) that are Philadelphia chromosome-positive. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), which block specific proteins responsible for cancer cell growth and proliferation. This medication is widely used in patients who are newly diagnosed or resistant to other therapies. In broader oncology treatment strategies, chemotherapy options like Capecitabine Tablets 500 Mg – Generic Xeloda may be used for solid tumors, while alternative dosing strengths such as Dasatinib Tablets 50 Mg – Generic Sprycel are prescribed based on patient tolerance and clinical response.

Mechanism of Action

Tyrosine Kinase Inhibition

Dasatinib Tablets 100 Mg works by inhibiting BCR-ABL tyrosine kinase, a protein produced by the Philadelphia chromosome that drives cancer cell growth in leukemia.

Blocking Cancer Cell Proliferation

By blocking this signaling pathway, it prevents cancer cells from multiplying and promotes their destruction. For detailed research insights, refer to National Cancer Institute (NCI) and for safety information, consult Mayo Clinic – Dasatinib Drug Information.

Medical Uses

Dasatinib Tablets 100 Mg – Generic Sprycel is used in:

• Chronic myeloid leukemia (CML)
• Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)

It is often prescribed when patients do not respond to other treatments or as a first-line therapy in specific cases.

Dosage and Administration

Dasatinib Tablets 100 Mg is usually taken once daily, with or without food, as prescribed by an oncologist. The dosage depends on the type of leukemia and patient response. In treatment planning, Capecitabine Tablets 500 Mg – Generic Xeloda is used in different cancer indications such as breast and colorectal cancers, while dose adjustments to Dasatinib Tablets 50 Mg – Generic Sprycel may be required based on tolerability and side effects.

Clinical Effectiveness

Clinical studies have shown that Dasatinib significantly improves response rates and disease control in patients with CML and Ph+ ALL. It is considered a highly effective targeted therapy in modern hematologic oncology.

Safety and Side Effects

Common Side Effects

• Fatigue
• Nausea
• Headache
• Fluid retention

Serious Risks

• Low blood cell counts
• Bleeding complications
• Pleural effusion (fluid around the lungs)
• QT prolongation (heart rhythm changes)

Regular monitoring is essential during treatment. For more details, refer to Mayo Clinic – Dasatinib Drug Information.

Contraindications and Precautions

Dasatinib Tablets 100 Mg should be used with caution in:

• Patients with heart conditions
• Individuals with liver impairment
• Patients at risk of bleeding disorders

It should not be used during pregnancy unless clearly prescribed.

Drug Interactions

Dasatinib Tablets 100 Mg may interact with medications that affect liver enzymes (CYP3A4 inhibitors/inducers), antacids, and other anticancer drugs. Patients should inform their healthcare provider about all medications they are taking. For research-based insights, refer to National Cancer Institute (NCI).

prescribed.

FAQs